Meyka Pro banner
Viatris Inc.

Viatris Inc. Fundamental Analysis (NASDAQ: VTRS)

VTRSNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$16.25
$0.03(0.15%)
U.S. Market is Open · 13:59

Viatris Inc. Fundamental Analysis (NASDAQ: VTRS)

Viatris Inc. (NASDAQ: VTRS) shows weak financial fundamentals with a PE ratio of -44.74, profit margin of -2.79%, and ROE of -2.79%. The company generates $14.8B in annual revenue with weak year-over-year growth of -2.98%.

Key Strengths

PEG Ratio-3.07
Current Ratio1.58

Areas of Concern

ROE-2.79%
Operating Margin-0.59%
We analyze VTRS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 12.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
12.9/100

We analyze VTRS's fundamental strength across five key dimensions:

Efficiency Score

Weak

VTRS struggles to generate sufficient returns from assets.

ROA > 10%
-1.17%

Valuation Score

Excellent

VTRS trades at attractive valuation levels.

PE < 25
-44.74
PEG Ratio < 2
-3.07

Growth Score

Weak

VTRS faces weak or negative growth trends.

Revenue Growth > 5%
-2.98%
EPS Growth > 10%
-4.66%

Financial Health Score

Excellent

VTRS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.96
Current Ratio > 1
1.58

Profitability Score

Weak

VTRS struggles to sustain strong margins.

ROE > 15%
-279.16%
Net Margin ≥ 15%
-2.79%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is VTRS Expensive or Cheap?

P/E Ratio

VTRS trades at -44.74 times earnings. This suggests potential undervaluation.

-44.74

PEG Ratio

When adjusting for growth, VTRS's PEG of -3.07 indicates potential undervaluation.

-3.07

Price to Book

The market values Viatris Inc. at 1.31 times its book value. This may indicate undervaluation.

1.31

EV/EBITDA

Enterprise value stands at 2.28 times EBITDA. This is generally considered low.

2.28

How Well Does VTRS Make Money?

Net Profit Margin

For every $100 in sales, Viatris Inc. keeps $-2.79 as profit after all expenses.

-2.79%

Operating Margin

Core operations generate -0.59 in profit for every $100 in revenue, before interest and taxes.

-0.59%

ROE

Management delivers $-2.79 in profit for every $100 of shareholder equity.

-2.79%

ROA

Viatris Inc. generates $-1.17 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.17%

Following the Money - Real Cash Generation

Operating Cash Flow

Viatris Inc. produces operating cash flow of $2.33B, showing steady but balanced cash generation.

$2.33B

Free Cash Flow

Viatris Inc. generates strong free cash flow of $1.88B, providing ample flexibility for dividends, buybacks, or growth.

$1.88B

FCF Per Share

Each share generates $1.61 in free cash annually.

$1.61

FCF Yield

VTRS converts 9.97% of its market value into free cash.

9.97%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-44.74

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-3.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.31

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.27

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.96

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.58

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.03

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How VTRS Stacks Against Its Sector Peers

MetricVTRS ValueSector AveragePerformance
P/E Ratio-44.7431.56 Better (Cheaper)
ROE-2.79%441.00% Weak
Net Margin-2.79%18300.00% Weak
Debt/Equity0.960.73 Weak (High Leverage)
Current Ratio1.585.63 Neutral
ROA-1.17%1512.00% Weak

VTRS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Viatris Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-38.53%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-169.45%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-3.45%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ